Director, Global Market Access Strategy, RWE, HEOR and Pricing

Scorpion Therapeutics; Gaithersburg (MD); On-site; USD 180,000 - 280,000; Full time

Job summary

Scorpion Therapeutics seeks a senior leader to drive global Market Access, HTA, pricing, and evidence generation for oncology products, with a focus on KIMMTRAK (tebentafusp). You will lead RWE/HEOR programs across 40+ countries and collaborate with Commercial, Medical, and Clinical teams to optimize launches and lifecycle management.

The role requires 10+ years in global Market Access for oncology, expertise in RWE/HEOR and patient-reported outcomes, and a track record of developing integrated

Qualifications

• 10+ years in global Market Access for oncology within a multinational biopharma.
• Expertise in RWE, HEOR, and patient-reported outcomes.
• Proven leadership in developing integrated evidence plans.
• Stakeholder management experience, especially in the US and European markets.

Responsibilities

• Develop and lead RWE and HEOR strategies across 40+ countries.
• Collaborate with Commercial, Medical, and Clinical teams to optimize product launch and lifecycle management.
• Oversee pricing and reimbursement negotiations.
• Manage evidence repositories.
• Shape pipeline strategies through early market access insights.

Skills

RWE

HEOR

Patient-reported outcomes

Leadership

Stakeholder management

Integrated evidence plans

Education

Advanced degree in Health Economics

Job description

Role

Senior leader responsible for global Market Access, HTA, pricing, and evidence generation strategies for oncology products, focusing on KIMMTRAK (tebentafusp).

Responsibilities

• develop and lead RWE and HEOR strategies across 40+ countries
• collaborate with Commercial, Medical, and Clinical teams to optimize product launch and lifecycle management
• oversee pricing and reimbursement negotiations
• manage evidence repositories
• shape pipeline strategies through early market access insights

Requirements

• 10+ years in global Market Access for oncology within a multinational biopharma
• expertise in RWE, HEOR, and patient-reported outcomes
• with proven leadership in developing integrated evidence plans
• stakeholder management experience, especially in the US and European markets

Preferred

• advanced degree in Health Economics
• experience with health policy or epidemiology
• exposure to international cultural considerations

HighValue

• Oncology (KIMMTRAK)
• global HTA and pricing strategies
• evidence generation
• US and international markets
• post-launch lifecycle management
• cross-functional collaboration
• stakeholder engagement

WorkSetup

~20% travel required.